Diagnostic tools based on artificial intelligence are now making their way into Norwegian hospitals. AI can independently ...
New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society ...
Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ...
The National Cancer Plan outlines a clear approach to improving cancer care, with the aim that by 2035, three in four people diagnosed with cancer will survive for at least five years.
What key experiences or clinical gaps motivated your focus on advancing prostate cancer diagnostics, particularly MRI-led ...
Prostate cancer is the most common cancer diagnosis in men, accounting for 30% of male cancers in 2025, and is the second ...
Diagnostic tools based on artificial intelligence are now making their way into Norwegian hospitals. AI can independently read X-ray images and detect bone fractures, or assess cancer tumors in both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results